A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J. Swen, Roelof Bosch, Cathelijne H. van der Wouden et al.|The Lancet|2023Cited by 508
Polysaccharides for the Delivery of Antitumor DrugsBianca Posocco, Barbara Dapas, Eva Dreussi et al.|Materials|2015Cited by 120
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic StrategiesMonica Mossenta, Giuseppe Toffoli|Cancers|2020Cited by 88
Strategies to optimize siRNA delivery to hepatocellular carcinoma cellsLucia Scarabel, Barbara Dapas, Francesca Perrone et al.|Expert Opinion on Drug Delivery|2017Cited by 28
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and EffectivenessRossella Farra, Barbara Dapas, Francesco Musiani et al.|Molecules|2018Cited by 28